This article is more than 5 years old. Information may no longer be current.
Zeiss appoints Steven Schallhorn as chief medical officer for global ophthalmic devices
Click Here to Manage Email Alerts
Steven C. Schallhorn, MD , has been appointed as chief medical officer for global ophthalmic devices at Carl Zeiss Meditec, the company announced in a press release.
He will serve on the executive leadership team and help direct business and medical guidance on the clinical use of the company’s portfolio of ophthalmic diagnostic and surgical technologies.
He will also work with academic institutions and key opinion leaders on research initiatives and development of practices for “improving clinical outcomes, practice efficiency and cost-effectiveness,” the release said.
Schallhorn, a San Diego-based refractive surgeon, has led multiple clinical studies and has presented to the FDA numerous times.
“Dr. Schallhorn’s medical expertise is pivotal to our clinical and medical affairs strategy and our partnership with doctors, clinical advisors, academia and ophthalmic associations,” Jim Mazzo, global president ophthalmic devices at Zeiss, said in the release.